Showing results (261-270 of 357) with videos related to
Sort By:
Pageof 36
Anticancer Research|August 8, 2009
Inhibition of proteasome activity by bortezomib in renal cancer cells is p53 dependent and VHL independentSusan A J Vaziri, Dale R Grabowski, Jason Hill, et al.Urologic Oncology|January 9, 2007
Phase II trial of capecitabine and rHu-interferon-alpha-2a in patients with metastatic renal cell carcinoma, limited efficacy, and moderate toxicityEna Segota, Tarek Mekhail, Thomas Olencki, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Phase I study of WR-2721 and carboplatinG T Budd, R Ganapathi, L Bauer, et al.Cancer Research|August 9, 2003
Disease stage variation in CD4+ and CD8+ T-cell reactivity to the receptor tyrosine kinase EphA2 in patients with renal cell carcinomaTomohide Tatsumi, Christopher J Herrem, Walter C Olson, et al.Cancer|January 8, 2009
A population-based study evaluating the impact of sunitinib on overall survival in the treatment of patients with metastatic renal cell cancerDaniel Y C Heng, Kim N Chi, Nevin Murray, et al.Anticancer Research|December 12, 2003
c-IAP1 is overexpressed in HL-60 cells selected for doxorubicin resistance: effects on etoposide-induced apoptosisSusan A Vaziri, Dale R Grabowski, Masahiro Tabata, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Multicenter, randomized, phase III trial of CD8(+) tumor-infiltrating lymphocytes in combination with recombinant interleukin-2 in metastatic renal cell carcinomaR A Figlin, J A Thompson, R M Bukowski, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1993
A randomized, double-blind trial of fluorouracil plus placebo versus fluorouracil plus oral leucovorin in patients with metastatic colorectal cancerL R Laufman, R M Bukowski, M A Collier, et al.Cancer|September 1, 2010
Sorafenib in patients with metastatic renal cell carcinoma refractory to either sunitinib or bevacizumabJorge A Garcia, Thomas E Hutson, Paul Elson, et al.Cancer|September 20, 2006
Thrombocytosis as a prognostic factor for survival in patients with metastatic renal cell carcinomaRevathi Suppiah, Philip E Shaheen, Paul Elson, et al.Pageof 36